• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Kathleen Blake Outlines How Burnout Affects Specialties Differently

Video

Looking at how burnout affects specialties differently shows that it’s not a work–life balance issues, but a systems one, said Kathleen Blake, MD, MPH, vice president for Performance Improvement at the American Medical Association.

Looking at how burnout affects specialties differently shows that it’s not a work—life balance issues, but a systems one, said Kathleen Blake, MD, MPH, vice president for Performance Improvement at the American Medical Association.

Transcript

Does the American Medical Association have information about how burnout affects different specialties?

Yes, and our 2 surveys published, so far, and the one that’s currently being analyzed, do break it down by physicians’ specialties. And we do look at the internal medicine subspecialties, which includes, of course, oncology. Where I find that data particularly interesting is that the field with the highest rate of burnout is emergency medicine, but the field with the highest favorable rating on work­—life balance is emergency medicine. So what that says to you, that paradox or seeming paradox, to me is really strong evidence: it’s not a work–life balance, it’s not a commitment problem, but that really have to focus on the systems problems.

Final words on the issue of burnout?

I think this is a treatable issue, a solvable problem. But I think if I leave the viewers with nothing else, I would want to say: it’s worth solving. It’s good for all of us. It’s good for clinicians, it’s good for health systems. But, most of all, it’s better for patients. And, quite frankly, we will all be patients at some point in our lives. I would really hope that we could have addressed this in a way so that we all have the kind of health and healthcare that we really want.

Related Videos
Shawn Kwatra, MD, dermatologist, John Hopkins University
Dr Laura Ferris Discusses Safety, Efficacy of JNJ-2113 in Patients with Plaque Psoriasis
dr krystyn van vliet
Martin Dahl, PhD, senior vice president, AnaptysBio
Jeff Stark, MD, vice president, head of medical immunology, UCB.
Jonathan Silverberg, MD, PhD, MPH, FAAD, professor of dermatology, director of clinical research and patch testing, George Washington University School of Medicine and Health Sciences
Monica Li, MD, University of British Columbia
Robert Sidbury, MD, MPH, FAAD, professor of pediatrics, division head of dermatology, Seattle Children's Hospital, University of Washington School of Medicine
Raj Chovatiya, MD, PhD, associate professor at the Rosalind Franklin University Chicago Medical School, founder and director of the Center for Medical Dermatology and Immunology Research
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.